Skip to main content
Article thumbnail
Location of Repository

Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A systematic review of randomized controlled trials

By X Jia, G McNeill and Alison Avenell

Abstract

Background Observational studies have shown associations between nutritional status and cognition in later life but evidence from intervention studies is unclear. The present study systematically reviewed the evidence on the effect of nutrient supplementation on cognitive function in people aged ≥65 years.\ud Methods Databases including MEDLINE and EMBASE were searched up to 1 September 2006. Randomized controlled trials using at least one kind of vitamin, mineral or omega-3 fatty acid, evaluating standardized neuropsychological test(s), were included. There were no restrictions on participants' baseline nutritional status or cognitive function. Quality assessment and data abstraction were conducted by one author and checked by another.\ud Results Of 4229 articles retrieved, 22 trials (3442 participants) were identified. Many were small, short duration and of poor methodology. Only 16 out of 122 cognitive tests were significantly different between groups. A meta-analysis showed no significant effect of taking B vitamins or antioxidant vitamins on global cognitive function. There was insufficient evidence to evaluate the effect of omega-3 fatty acids on any cognitive domains.\ud Conclusion There was little evidence of a beneficial effect from taking B vitamins or antioxidant supplements on global cognitive function in later life. Larger-scale randomized controlled trials of longer duration in selected age groups are needed.Institute of Applied Health Science, University of Aberdeen; \ud Chief Scientist Office of the Scottish Government Health Directorates; \ud Chief Scientist of the Scottish Government Health Directorate

Topics: cognition, older people, dietary supplements, systematic review, meta-analysis
Publisher: Blackwell
Year: 2008
OAI identifier: oai:aura.abdn.ac.uk:2164/290
Journal:

Suggested articles

Citations

  1. (1997). 25 Study Participants Intervention Outcomes Fioravanti
  2. (2003). 26 Study Participants Intervention Outcomes Sommer
  3. (2006). A controlled trial of homocysteine lowing and cognitive performance. doi
  4. (1984). A new rating scale for Alzheimer’s disease.
  5. (2002). A randomized, double-blind, placebo-controlled study of oral vitamin B12supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. doi
  6. (2004). Age-Related Eye Disease Study Research Group.
  7. (1999). Anti-oxidant vitamins and mental performance of the elderly. doi
  8. (2004). Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. doi
  9. (2006). Available at: URL: http://www.updatesoftware.com/national/nrr-frame.html (accessed 1
  10. (1995). Beta-carotene intervention trial in premalignant gastric lesions.
  11. (2006). Beyond ageing: a study for the prevention of depression, cognitive impairment and the improvement of knowledge about mental health. The U.S. National Institute of Health Clinical Trial Database. Available from:
  12. (2004). Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study. doi
  13. (2006). Community Research and Development Databases. Available from: URL: http:// www.cordis.lu/en/home.html (accessed 1
  14. (1990). Depression in dementia of the Alzheimer type and in multi-infarction dementia. doi
  15. (1991). Dietary reference values for food energy and nutrients for the United Kingdom. doi
  16. (1999). Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. doi
  17. (2000). E for Alzheimer's disease. Cochrane Database Sys. doi
  18. (2007). Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. doi
  19. (2001). Effect of vitamin and trace element supplementation on cognitive function in elderly subjects. [retracted in Nutrition doi
  20. (2004). Effectiveness of nutritional supplements on cognitive functioning in elderly persons: a systematic review. doi
  21. (1996). Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. doi
  22. (1996). Folate, vitamin B-12, and neuropsychiatric disorders. doi
  23. (2003). Folic acid supplementation in dementia: a preliminary report. doi
  24. (2003). Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Sys. doi
  25. (2003). for Alzheimer's disease. Cochrane Database of Sys.
  26. (1997). Fourniere doi
  27. (1997). Growth suppression and induction of heat-shock protein-70 by 9-cis beta-carotene in cervical dysplasia-derived cells. doi
  28. (2002). Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults. Drug. Aging doi
  29. (2006). Homocysteine and B vitamins in cognitive impairment. The International Standard Randomized Controlled Trail. Available from: URL:
  30. (1999). Homocysteine and vascular disease. doi
  31. (2003). In the meta-analysis (Figure 2), SD of mean change was available for Clarke et al.,
  32. (1998). In the meta-analysis (Figure 2), SD of mean change was available for Kwok et al.,
  33. (1996). Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. doi
  34. (1997). Intervention Outcomes Sano
  35. (1999). Intervention Outcomes Terano
  36. (2000). IU for 2 years. (b) Double-blind placebo for 2 years. Allocation: (a) 84, (b) 85. % Dropout: (a) 5%, (b) 7%. Follow up: 2 years.
  37. (1964). L’examen clinique en psychologie. Paris : Presses Universitaries de France.
  38. (1997). Low folate levels in the cognitive decline of elderly patients and efficacy of folate as a treatment for improving memory deficies. doi
  39. (2003). Meausring inconstancy in meta-analyses.
  40. (2006). Mental health in Elderly Maintained with omega-3. Current controlled trials. Available from: URL:
  41. (2002). MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high risk individuals: a randomised placebo controlled trial. doi
  42. (2004). No effect of vitamin B12 treatment on cognitive function and depression: a randomized placebo controlled study. doi
  43. (2001). Nutrient dense foods and exercise in frail elderly effects on B vitamins homocysteine methylmalonic acid and neuropsychological functioning.
  44. (2007). Nutrition in brain development and aging: role of essential fatty acids. doi
  45. (2005). Nutritional supplementation for hip fracture aftercare in older people. The Cochrane Database of Sys. doi
  46. (2004). Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Sys. doi
  47. (2006). Omega-3 fatty acid for the prevention of dementia. Cochrane Database Sys. doi
  48. (1993). Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. doi
  49. (2002). Outcomes: digital span forward, Wechsler Memory Scale : Verbal Fluency (initial letter), risk of nurient deficiencies. RDA, Recommended Daily Allowance; SD, Standard Deviation; 30 Table 5. Quality assessment of included trials Study Allocation
  50. (1993). placebo made from lactose orally daily for 1 month, then vitamin B1 for 1 month. Allocated: (a) 9, (b) 9. Follow up: 2 months Outcomes: ADAS-cog, MMSE, adverse events. Passeri
  51. (1992). Posatirelin for the treatment of late-onset Alzheimer's disease: A double-blind multicentre study vs citicoline and ascorbic acid. doi
  52. (1993). Preliminary findings of high-dose thiamine in dementia of Alzheimer's type. doi
  53. (1999). quality of life: dependence scale, behavior rating scale for dementia, institulization, adverse events. Smith
  54. (2005). Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease.
  55. (2006). Randomized Controlled Trials. Available from: URL: http://www.controlledtrials.com/isrctn/ (accessed 1
  56. (2007). Reaction Time test, plasma homocysteine, folate, vitamin B6, B12 and RBC folate status. McNeill
  57. (2002). RevMan Analyses [Computer program] Version 1.0 for Windows.
  58. (2005). Role of multivitamins and mineral supplements in preventing infections in elderly people: systematic review and meta-analysis of randomised controlled trials. doi
  59. (2003). serum vitamin B12, plasma homocysteine, blood folate status. Clarke
  60. (1992). Setting : community healthy volunteers, Netherlands. Sex: 82M Age: mean (SD) years: (a) 73 (3), (b) 73 (3). Nutrient status: 13 marginal vitamin B6 deficiency, (a) 4, (b) 9. IQ > 80, mean (SD) : (a)
  61. (2001). Setting: freeliving frail elderly from health center, BMI<=25 or had recent weight loss, the Netherlands. Sex: 21M, 45F. Age: mean (SD): (a) 78.8 (4.8), (b) 79.0 (7.2). (a) 13 vitamins and minerals
  62. (2000). Setting: healthy volunteers, Switzerland. Sex: 51M, 88F Age: mean (SD): (a) 70.7 (5.6), (b) 70.2 (5.4). (a) 10 vitamins and minerals 1-10 times RDA, USA, for 24 weeks. (b) Double-blind placebo made from rape seed oil for 24 weeks. Allocation:
  63. (1993). Setting: patient, living with caretaker who paid particular attention to nutrient intake,
  64. (2002). Setting: two geriatric hospitals, Australia. Sex: 14M, 17F. Age: mean years: (a) 84.9, (b) (82.0), (c) (77.6). Nutrient status: Serum vitamin B12 100-150 pmol/l. Mental status: 1/3 dementia MMSE: mean (SD): (a)
  65. (2002). Short-Term Folate, Vitamin B-12 or Vitamin B-6 Supplementation Slightly Affects Memory Performance But Not Mood in Women of Various Ages.
  66. (2004). Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
  67. (2003). The effect of vitamin B6 on cognition. Cochrane Database Sys. doi
  68. (2000). The influence of multivitamins on cognitive function and mood in the elderly. Aging Ment. doi
  69. (2007). the MAVIS Trial Group. doi
  70. (2005). The US National Institutes of Health clinical trials database. Available from: URL: http://clinicaltrials.gov/ct//show/NCT00040378? (accessed 1
  71. (2006). VITAL – Vitamin to slow Alzheimer’s disease (homocysteine study) The U.S. National Institute of Health Clinical Trials Database. Available from: URL: http://www.clinicaltrials.gov/show/NCT00056225 (accessed 1
  72. (1992). Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. doi
  73. (1997). Vitamin B12 deficiency and dementia: A multicenter epidemiologic and therapeutic study. Preliminary therapeutic trial. Semaine Des Hopitaux 73(5-6),
  74. (2003). Vitamin B12 for cognition. Cochrane Database Sys. doi
  75. (2005). Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Sys. doi
  76. (1997). Vitamin/mineral supplementation and cancer risk: international chemoprevention trials. doi
  77. (2000). Why we need a broad perspective on meta-analysis. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.